GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art

BACKGROUND: GLP-1 receptor agonists (GLP-1 RAs) with exenatide b.i.d. first approved to treat type 2 diabetes in 2005 have been further developed to yield effective compounds/preparations that have overcome the original problem of rapid elimination (short half-life), initially necessitating short in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Metab
Main Authors: Nauck, Michael A., Quast, Daniel R., Wefers, Jakob, Meier, Juris J.
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2020
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8085572/
https://ncbi.nlm.nih.gov/pubmed/33068776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2020.101102
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker